Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Effexus Pharmaceutical
Unknown, Kansas, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Effexus Pharmaceutical is a private pharmaceutical company based in Kansas, United States. Its lead clinical asset is a combination of lansoprazole and omeprazole targeting the proton pump for gastrointestinal indications such as Barrett esophagus and erosive esophagitis. The company has conducted at least three clinical trials with its main program reaching Phase 2. There are no recent reports of commercialized products or late-stage assets[1].
- Therapeutic areas
- GastroenterologyOncology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Effexus Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Effexus Pharmaceutical.